Cognitive impairments in Parkinson's disease
1Neurology Department of Xuanwu Hospital, Capital Medical University, Beijing, China.
Aging & Mental Health
|December 1, 2011
Summary
Cognitive impairment (CI) in Parkinson's disease (PD) progresses with age and disease severity. Advanced age, late onset, and initial visuospatial deficits predict worsening CI in PD patients.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Cognitive impairment (CI) and dementia are prevalent in Parkinson's disease (PD), significantly impacting patient outcomes.
- Understanding prognostic factors for CI in PD is crucial for timely intervention and management.
Purpose of the Study:
- To investigate the predictive factors associated with the progression of cognitive impairment in patients diagnosed with Parkinson's disease.
Main Methods:
- A cohort of 102 Parkinson's disease patients from 2005-2010 underwent clinical and neurological assessments.
- Demographic and performance data were analyzed to identify variables independently linked to cognitive impairment progression.
- Follow-up durations varied, including 6-month, 6-month-to-2-year, and 2-to-5-year intervals.
Main Results:
- Cognitive impairment progression rates increased with follow-up time: 5% at 6 months, 15% at 6 months-2 years, and 45% at 2-5 years.
- Worsening CI was significantly associated with older age, particularly in the longer follow-up groups.
- Age at onset and initial disease severity were also identified as significant predictors of CI progression.
Conclusions:
- Advanced age, later disease onset, and greater Parkinson's disease severity are key predictors of cognitive impairment progression.
- Patients exhibiting initial severe visuospatial function impairments face the highest risk of cognitive decline.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...